Bossowska A, Majewski M
Department of Human Physiology, Faculty of Medical Sciences, University of Warmia and Mazury, Warszawska 30, 10-082 Olsztyn, Poland.
Pol J Vet Sci. 2012;15(1):135-42. doi: 10.2478/v10181-011-0124-6.
Although resiniferatoxin (RTX) becomes more often used in experimental therapies of sensory system disorders, so far there is no data concerning the influence of RTX on the chemical coding of neurons in dorsal root ganglia (DRG) supplying the urinary bladder in the pig, an animal species considered as a reliable animal model for investigation dealing with human lower urinary tract disorders. Retrograde tracer Fast Blue (FB) was injected into the wall of the right half of the urinary bladder in six juvenile female pigs, and three weeks later, bladder instillation of RTX (500 nmol per animal) was carried out in all the animals. After a week, DRGs were harvested from all the pigs and the neurochemical characterization of FB+ neurons was performed using routine single-immunofluorescence labeling technique on 10-microm-thick cryostat sections. RTX instillation resulted in a distinct decrease in the numbers of FB+ cells containing calcitonin gene-related peptide (CGRP), nitric oxide synthase (NOS), somatostatin (SOM) and calbindin (CB) when compared with those found in the healthy animals (18% vs. 36%, 1% vs. 6%, 0.8% vs. 4% and 0.5% vs. 3%, respectively), and an increase in the number of pituitary adenylate cyclase-activating polypeptide (PACAP)- and galanin (GAL)-immunoreactive (IR) nerve cells (51% vs. 26% and 47% vs. 6.5%). The results obtained suggest that RTX could be taken into consideration when the neuroactive agents are planned to be used in experimental therapies of selected neurogenic bladder illnesses.
尽管树脂毒素(RTX)在感觉系统疾病的实验性治疗中使用得越来越频繁,但迄今为止,尚无关于RTX对猪膀胱背根神经节(DRG)中神经元化学编码影响的数据,猪被认为是研究人类下尿路疾病的可靠动物模型。将逆行示踪剂快蓝(FB)注入六只幼年雌性猪右半侧膀胱壁,三周后,对所有动物进行膀胱灌注RTX(每只动物500 nmol)。一周后,从所有猪身上采集DRG,并使用常规单免疫荧光标记技术在10微米厚的低温切片上对FB+神经元进行神经化学特征分析。与健康动物相比,灌注RTX导致含有降钙素基因相关肽(CGRP)、一氧化氮合酶(NOS)、生长抑素(SOM)和钙结合蛋白(CB)的FB+细胞数量明显减少(分别为18%对36%、1%对6%、0.8%对4%和0.5%对3%),而垂体腺苷酸环化酶激活多肽(PACAP)和甘丙肽(GAL)免疫反应性(IR)神经细胞数量增加(分别为51%对26%和47%对6.5%)。所得结果表明,在计划将神经活性剂用于选定神经源性膀胱疾病的实验性治疗时,可考虑使用RTX。